Lithium Controlled-Release and Extended-Release Tablets and Uridine triacetate
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Uridine triacetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: uridine
Brand name: Vistogard, Xuriden
Synonyms: Uridine Triacetate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Uridine Triacetate (Vistogard)
- Lithium Controlled-Release and Extended-Release Tablets-Uridine Triacetate (Xuriden)
- Lithium Controlled-Release and Extended-Release Tablets-Urimar-T
- Lithium Controlled-Release and Extended-Release Tablets-Urin D/S
- Lithium Controlled-Release and Extended-Release Tablets-Urinary Pain Relief
- Lithium Controlled-Release and Extended-Release Tablets-Urispas
- Uridine triacetate-Lithium ER
- Uridine triacetate-Lithium Oral Solution
- Uridine triacetate-Lithium Salts
- Uridine triacetate-Lithium Syrup and Oral Solution
- Uridine triacetate-Lithobid
- Uridine triacetate-Lithostat